Absence of epidermal growth factor receptor mutations in cervical cancer, International Journal of Gynecological Cancer, vol.18, issue.4, pp.749-754, 2008. ,
DOI : 10.1111/j.1525-1438.2007.01111.x
in Colorectal Cancers and Glioblastomas, New England Journal of Medicine, vol.351, issue.27, pp.2883-2886, 2004. ,
DOI : 10.1056/NEJM200412303512724
Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer, Journal of Clinical Oncology, vol.23, issue.11, pp.2445-59, 2005. ,
DOI : 10.1200/JCO.2005.11.890
NASOPHARYNGEAL CARCINOMA IN TURKISH CHILDREN: Review of 33 Cases, Pediatric Hematology and Oncology, vol.80, issue.5, pp.309-315, 2001. ,
DOI : 10.1002/1097-0142(197606)37:6<2787::AID-CNCR2820370633>3.0.CO;2-O
EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies, Trends in Microbiology, vol.12, issue.8, pp.356-60, 2004. ,
DOI : 10.1016/j.tim.2004.06.005
URL : https://hal.archives-ouvertes.fr/hal-00122928
Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: No significant correlations with clinicopathological variables and treatment outcomes, Int. J ,
Genetic Alterations in Primary Glioblastomas in Japan, Journal of Neuropathology and Experimental Neurology, vol.65, issue.1, pp.12-18, 2006. ,
DOI : 10.1097/01.jnen.0000196132.66464.96
Cancer incidence mortality and prevalence worldwide. IARC Cancer Base n:5, 2001. ,
The ErbB receptor tyrosine family as signal integrators, Endocrine Related Cancer, vol.8, issue.3, pp.151-159, 2001. ,
DOI : 10.1677/erc.0.0080151
Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells, International Journal of Cancer, vol.4, issue.1, pp.209-214, 2006. ,
DOI : 10.1002/ijc.21290
Carcinoma of the nasopharynx; analysis of treatment results in 167 consecutively admitted patients. Head and Neck, pp.200-207, 1992. ,
EGFR mutation and resistance of nonsmall-cell-lung cancer to gefitinib. New Engl, J. Med, vol.352, pp.786-792, 2005. ,
Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer and Acquired Resistance to Gefitinib, Clinical Cancer Research, vol.12, issue.19, pp.5764-5773, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-0714
Nasopharyngeal carcinoma in Saudi Arabia: A retrospective study of 166 cases treated with curative intent, International Journal of Radiation Oncology*Biology*Physics, vol.15, issue.5 ,
DOI : 10.1016/0360-3016(88)90193-9
Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib, The Pharmacogenomics Journal, vol.61, issue.2, pp.129-138, 2008. ,
DOI : 10.1158/1055-9965.EPI-04-0612
Nasopharyngeal carcinoma in childhood, Medical and Pediatric Oncology, vol.20, issue.3, pp.243-50, 1982. ,
DOI : 10.1002/mpo.2950100304
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.350, issue.21, pp.2129-2139, 2004. ,
DOI : 10.1056/NEJMoa040938
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma?a prospective study, Head & Neck, vol.3, issue.10, pp.25864-72, 2003. ,
DOI : 10.1002/hed.10307
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response, Invest. New. Drugs, vol.3, pp.326-359, 2010. ,
Mutations in Non???Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment, Journal of Clinical Oncology, vol.23, issue.4, pp.857-865, 2005. ,
DOI : 10.1200/JCO.2005.08.043
Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.10, issue.1, pp.136-143, 2004. ,
DOI : 10.1158/1078-0432.CCR-0373-3
Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non???Small-Cell Lung Cancer: Current Knowledge and Future Directions, Journal of Clinical Oncology, vol.23, issue.11, pp.2556-2568, 2005. ,
DOI : 10.1200/JCO.2005.07.799
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc. Natl. Acad. Sci, pp.13306-13311, 2004. ,
DOI : 10.1073/pnas.0405220101
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy, Science, vol.304, issue.5676, pp.1497-1500, 2004. ,
DOI : 10.1126/science.1099314
Nasopharyngeal carcinomas, European Journal of Cancer, vol.39, issue.15, pp.2121-2135, 2003. ,
DOI : 10.1016/S0959-8049(03)00367-8
Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells, pp.237-282, 2005. ,
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.5, pp.1229-1263, 2001. ,
DOI : 10.1016/S0360-3016(00)01588-1
Mutation and polymorphism in the EGFR-TK domain associated with lung cancer, J. Thorac. Oncol, vol.1, pp.635-647, 2006. ,